iBio, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
IBIO on NYSE
Industry
Pharmaceutical Preparations
Location
600 Madison Avenue, Suite 1601, New York, NY

Insiders trading volume in the past year

iBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Antonio Bernardino Guimaraes Parada Director $500K +$500K Jan 10, 2025
Randy Joe Maddux Chief Operating Officer $72.2K Dec 7, 2021
David Arkowitz Director $50K +$50K Jan 10, 2025
Martin Brenner Chief Executive Officer and Chief Scientific Officer, Director $49.8K +$25K +101% Feb 21, 2025
Felipe Duran Chief Financial Officer $30.3K +$25K +472% Feb 21, 2025
Marc Banjak Chief Legal Officer $30.1K +$25K +490% Feb 21, 2025
Robert Lutz Chief Financial & Business Officer and Principal Accounting Officer $27.1K Nov 11, 2022
Gary Sender Director $25K +$25K Jan 10, 2025
William D. Clark Director $5K +$5K Jan 10, 2025
HILL (Ret) GENERAL Director Dec 9, 2021
Linda Washington Armstrong Director Dec 9, 2021
John D. Mckey Jr Director Dec 9, 2021
Evert B. Schimmelpennink Director Nov 21, 2024
Glenn Chang Director Dec 9, 2021
Thomas Francis 3rd Isett CEO and Executive Chairman, Director Sep 8, 2022
Alexandra Kropotova Director Nov 21, 2024

Recent Insider Transactions by Companies or Individuals for iBio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.